Health & BioTech
LENZ Therapeutics Lands a New China Partner and an $85 Million Opportunity for its Eye Drop
Presbyopia affects an estimated 1.8 billion people worldwide, yet for most of its history, the only practical solutions were reading glasses, contact lenses, or surgery....
Rett Syndrome Has No Approved Cure. Neurogene is Trying to Change That
Rett syndrome is a rare and severe neurological disorder that affects brain development, almost exclusively in girls. It typically appears after a period of normal...
Verastem Adds Another FDA Fast Track as it Targets a Hard to Treat Lung Cancer
Verastem Oncology, Inc. (NASDAQ: VSTM) has added another regulatory milestone for VS 7375, a drug still in early testing but now carrying a second Fast...
How a Blood Cancer Drug Trial Result Sent a Small-Cap Biotech Stock Plummeting
Biotech companies often face a defining moment when their most important clinical trial results arrive. This is especially true for companies working on cancer treatments...
Two Drugs, One Deadly Cancer and a New Collaboration Between a Small Biotech and a Pharma Giant
Pancreatic cancer has long been one of the most difficult cancers to treat. Survival rates remain grim, with only about 13% of patients alive five...
Aveanna Healthcare Expands its Pediatric Care Network with a $175.5 Million All-Cash Purchase
Home care is not a flashy corner of the healthcare industry, but it is becoming one of the more consequential ones. When medically complex patients,...
Younger Drinkers Are Changing the Spirits Market
Younger adults are drinking less, and that change is starting to show up far beyond the cocktail glass. A 2025 Gallup poll found that 54%...
Three Hard-to-Treat Cancers, One Experimental Combination, and Remarkable Early Data
There is a particular reason that oncologists have long considered KRAS-mutated cancers to be among the most difficult to treat. The gene mutation, which appears...
Three Times Longer Without a Seizure and Almost None of the Side Effects
Most people living with epilepsy are not just managing seizures. They are managing fatigue, mental fog, dizziness and drowsiness that come bundled with the medications...
New Cancer Drug Data Pushes Frontline Lung Cancer Treatment into a New Chapter
Oncology drug development is entering a phase where the most interesting questions are not just about whether a therapy can shrink a tumor, but about...
